ArticleTherapeutic advances in medical oncology2025

Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study.

Qi-An Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.